Table 1.
Demographic and clinical characteristics of study participants.
| Characteristics | HPV+ Persistence group (n = 20) |
HPV+ Clearance group (n = 21) |
P-value |
|---|---|---|---|
| Age range (mean ±SE) | 24–61 (37.86±2.53) | 22–52 (31.96±1.78) | 0.14a |
| HPV type, n (%) | Persistent HR-HPV 20 (100%) | HPV negative 0 (0%) | <0.001b |
| ThinPrep cytological test, n (%) | Inflammatory reaction 12 (60.00%) |
Inflammatory reaction 11 (52.38%) |
0.76b |
| Abnormal vaginal discharge, n (%) | WBC++ 5 (25.00%) | WBC++ 6 (28.57%) | 1.00b |
| Mycoplasma, n (%) | 6 (30.00%) | 6 (28.57%) | 1.00b |
| Chlamydia, n (%) | 0 (0%) | 0 (0%) | / |
| Neisseria gonorrhoeae, n (%) | 0 (0%) | 0 (0%) | / |
| Colposcopy+biopsy, n (%) | CIN 3 (15.00%) | 0 (0%) | 0.11b |
a
Independent t-test.
b
Kruskal-Wallis test.
cP-value < 0.05 considered significant.